ADIL SCHEDULE 13G/A: SEC filing
An amendment to a Schedule 13G was
Filed with the SEC on · accession 0001104659-26-121888
ADIL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 3, 2026. An amendment to a Schedule 13G was filed regarding beneficial ownership of Azora Therapeutics, Inc. (ADIL).
Summary of the filing
An amendment to a Schedule 13G was filed regarding beneficial ownership of Azora Therapeutics, Inc. (ADIL). The filing indicates a change in a passive institutional holder's ownership position.
Key details
✦ Ask GOAX AI about this filing — what it means for ADIL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ADIL?
Click hereFrequently asked questions
What did ADIL file with the SEC on Nov 3, 2026?
ADIL filed a SCHEDULE 13G/A (SEC filing). An amendment to a Schedule 13G was filed regarding beneficial ownership of Azora Therapeutics, Inc. (ADIL). The filing indicates a change in a passive institutional holder's ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other ADIL SEC filings
Get alerts when ADIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days